Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2023-02-14 12:05 pm Purchase | 13G | CHINOOK THERAPEUTICS INC KDNY | Frazier Life Sciences Public Fund L.P. | 4,052,510 6.3% | 1,282,484 (+46.30%) | View |
| 2023-02-14 12:03 pm Sale | 13G | GRACELL BIOTECHNOLOGIES INC SP GRCL | Frazier Life Sciences Public Fund L.P. | 0 0% | -17,104,865 (Position Closed) | View |
| 2023-02-14 11:58 am Purchase | 13G | ALLAKOS INC ALLK | Frazier Life Sciences Public Fund L.P. | 4,792,000 5.6% | 1,892,000 (+65.24%) | View |
| 2023-01-23 12:17 pm Purchase | 13G | THESEUS PHARMACEUTICALS INC CO THRX | Frazier Life Sciences Public Fund L.P. | 2,248,194 5.8% | 2,248,194 (New Position) | View |
| 2022-12-30 2:15 pm Purchase | 13D | KALVISTA PHARMACEUTICALS INC C KALV | Frazier Life Sciences Public Fund L.P. | 3,238,859 9.5% | 1,666,667 (+106.01%) | View |
| 2022-10-07 2:51 pm Purchase | 13G | TREVI THERAPEUTICS INC TRVI | Frazier Life Sciences Public Fund L.P. | 6,663,590 11.4% | 2,847,131 (+74.60%) | View |
| 2022-09-12 1:58 pm Purchase | 13G | ALLAKOS INC ALLK | Frazier Life Sciences Public Fund L.P. | 2,900,000 5.3% | 2,900,000 (New Position) | View |
| 2022-09-08 1:19 pm Purchase | 13D | HILLEVAX INC HLVX | Frazier Life Sciences Public Fund L.P. | 9,637,232 28.8% | 513,660 (+5.63%) | View |
| 2022-08-12 12:35 pm Sale | 13G | VIRIDIAN THERAPEUTICS INC VRDN | Frazier Life Sciences Public Fund L.P. | 300,000 1.1% | -1,205,200 (-80.07%) | View |
| 2022-05-16 12:57 pm Purchase | 13G | TRICIDA INC TCDA | Frazier Life Sciences Public Fund L.P. | 3,582,093 6.3% | 3,582,093 (New Position) | View |
| 2022-05-06 4:15 pm Purchase | 13D | HILLEVAX INC HLVX | Frazier Life Sciences Public Fund L.P. | 9,123,572 27.3% | 9,123,572 (New Position) | View |
| 2022-04-29 12:19 pm Purchase | 13G | CHINOOK THERAPEUTICS INC KDNY | Frazier Life Sciences Public Fund L.P. | 2,770,026 5% | 2,770,026 (New Position) | View |
| 2022-04-18 1:32 pm Purchase | 13G | TREVI THERAPEUTICS INC TRVI | Frazier Life Sciences Public Fund L.P. | 3,816,459 10% | 3,816,459 (New Position) | View |
| 2022-03-29 4:23 pm Purchase | 13G | SIERRA ONCOLOGY INC SRRA | Frazier Life Sciences Public Fund L.P. | 2,366,853 10% | 1,562,186 (+194.14%) | View |
| 2022-03-17 12:42 pm Purchase | 13G | GRACELL BIOTECHNOLOGIES INC SP GRCL | Frazier Life Sciences Public Fund L.P. | 17,104,865 5.1% | 17,104,865 (New Position) | View |
| 2022-03-01 2:40 pm Purchase | 13G | COGENT BIOSCIENCES INC COGT | Frazier Life Sciences Public Fund L.P. | 2,188,004 11% | 2,188,004 (New Position) | View |
| 2022-01-31 5:00 pm Purchase | 13D | KALVISTA PHARMACEUTICALS INC C KALV | Frazier Life Sciences Public Fund L.P. | 1,572,192 6.4% | 303,463 (+23.92%) | View |
| 2022-01-28 1:41 pm Purchase | 13G | PARDES BIOSCIENCES INC PRDS | Frazier Life Sciences Public Fund L.P. | 2,457,507 3.9% | 2,457,507 (New Position) | View |
| 2022-01-28 1:39 pm Purchase | 13G | VIRIDIAN THERAPEUTICS INC VRDN | Frazier Life Sciences Public Fund L.P. | 1,505,200 6.9% | 200,000 (+15.32%) | View |
| 2021-12-30 4:33 pm Purchase | 13D | KALVISTA PHARMACEUTICALS INC C KALV | Frazier Life Sciences Public Fund L.P. | 1,268,729 5.2% | 1,268,729 (New Position) | View |